Background: Stroke is one of the leading factors of morbidity and mortality worldwide. It represents the second most common cause of mortality in Taiwan. Hypertension is an important and established modifiable risk factor and predictor for stroke. Although many studies had demonstrated treatment of hypertension can reduce morbidity and mortality of stroke patients. But still had many stroke patients inadequate management of hypertension despite explicit management recommendations. There are marked rooms for improvement in the management of hypertension. Objective: To determine the efficacy of pharmacist intervention in the management of hypertension in the neurologic stroke outpatient. Method: This was a prospective and equal allocation stratified random sampling clinical trial. One-hundred sixty patients were randomly assigned to experimental (n=80) or control (n=80) group. The experimental group received pharmacist intervention while the control group did as routine. Primary endpoints were (1) the differences of within groups and between groups of systolic blood pressure, diastolic blood pressure levels from baseline to the end of study. (2) the proportion of adequate management or assessed improvement of hypertension from baseline to the end of study.
Results: In the experimental group had significant improvement in systolic blood pressure and diastolic blood pressure. In the control group did not improved in blood pressure. Hypertension adequate management improved 37 % (P = 0.00) in the experimental group. There was no significant improvement in hypertension adequate management in the control group. Conclusion: Our study was indicated that pharmacist-managed hypertension program integrated into a primary care medical clinic can effectively improve blood pressure control in stroke outpatients and positive impact on patient health care outcomes.
